60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Debt to Equity Ratio : 0.0578 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0578 |
| March 31, 2026 | 0.0315 |
| December 31, 2025 | 0.0441 |
| September 30, 2025 | 0.0347 |
| June 30, 2025 | 0.0635 |
| March 31, 2025 | 0.0378 |
| December 31, 2024 | 0.0386 |
| September 30, 2024 | 0.0259 |
| June 30, 2024 | 0.0519 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.022 |
| December 31, 2023 | 0.0355 |
| September 30, 2023 | 0.0287 |
| June 30, 2023 | -1.154 |
| March 31, 2023 | -1.239 |
| September 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -1.072 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Harrow, Inc. | 19.79 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.283M |
| Total Liabilities (Quarterly) | 1.754M |
| Shareholders Equity (Quarterly) | 2.614M |
| Current Ratio | 2.325 |
| Net Debt Paydown Yield | 0.02% |